Visit: 60 Corporate Woods, Suite 380 | Email: URVenturesInfo@urmc.rochester.edu | Phone: 585-276-6600
Oscine Therapeutics – a biotechnology company that is developing cell-based therapies for neurological disorders based on discoveries made at the University of Rochester Medical Center (URMC) – has been acquired by Sana Biotechnology for undisclosed terms. The research behind Oscine is based on decades of work in the lab of Steve Goldman,
University of Rochester startup, Simulated Inanimate Models (SIM), received the Outstanding Graduate Award and $400,000 in Round 3 of the Luminate NY competition. Luminate NY, which is administered by NextCorps, is the world’s largest business accelerator for startup firms that have optics, photonics and imaging enabled technologies. SIM manufactures surgical
Innov8 is a new eight-week program designed to help emerging entrepreneurs develop their business concepts, hone business strategies, and build a business plan with actionable steps. This program provides entrepreneurial training and modest grant funding to University students, faculty, staff, and alumni interested in developing or commercializing any type of
Want to further your understanding around IP, entrepreneurship and commercialization? URventures has compiled a list of educational resources to help you get started! We will be routinely updating and adding to this list, and welcome your feedback.
A new study shows that when specific human brain cells are transplanted into animal models of multiple sclerosis and other white matter diseases, the cells repair damage and restore function. The study provides one of the final pieces of scientific evidence necessary to advance this treatment strategy to clinical trials.
The NSF I-Corps Upstate New York (UNY) Node is offering a short course program for researchers interested in exploring the market potential of their work and learning entrepreneurial skills. Short Courses—geared toward faculty, doctoral candidates, and postdocs—are offered at no cost to participants and consist of both in-person and remote
CNY Biotech Accelerator, a division of the State University of New York Upstate Medical University, located in Syracuse, NY, is seeking medical device innovators for its annual 6-month grant-funded Medical Device Innovation Challenge (MDIC). Applications from US-based innovators are accepted January 1 – May 31, 2020. Selected participants receive 6-months
The University of Rochester has joined together with the University of Buffalo and Roswell Park Comprehensive Cancer Center to form Empire Discovery Institute, a new drug discovery partnership. EDI aims to convert the institutions’ scientific breakthroughs into viable pharmaceuticals for commercialization and to strengthen the region as a hub for
Oscine Therapeutics, a new biotechnology company based on discoveries made and developed at the University of Rochester Medical Center (URMC) has received a significant multi-year investment to support both research and development of cell-based therapies for neurological disorders. The funding represents the largest-ever investment in a URMC start-up company. The
University of Rochester start-up, VPG Medical, was recently featured in the Rochester Business Journal: VPG Medical uses unconventional tech for heart care Among the companies in the Luminate NY accelerator, VPG Medical Inc. is a bit unique. While most companies in the accelerator are based around developing hardware products in
Learning a musical instrument requires dedication, practice, and time. Making performance errors is a natural part of the learning process; however, learning delays can occur when errors go uncorrected during individual practice. A recently established startup company, Shenzhen Mango Future Education Technology Co (Mango Future), has developed a product to
Rochester-based Health Care Originals (HCO), is a leading digital health startup, integrating IoT technologies to empower everyone through improved understanding and management of their health and medical conditions. HCO’s current wearable solutions are optimized for respiratory system applications, providing revolutionary, actionable insight into illnesses like asthma and COPD, respiratory syndromes,
Health Care Originals, a leading digital health startup commercializing patented University of Rochester technology, announced that former Chief Executive Officer of University of Rochester Medical Center, Dr. Bradford Berk, has joined its Board of Directors. Read more.
Koning Corporation’s breast computed tomography (KCBT 1000) system was nominated for Best Medical Technology at the 12th annual Prix Galien awards. The Prix Galien awards recognize outstanding achievements in improving the human condition through the development of innovative therapies. Worldwide, the Prix Galien is regarded as the equivalent of the